Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika Plc

Ilika’s Stereax solid-state battery technology will be showcased at MedTech Ireland 2026 through Cirtec Medical, highlighting its potential use in active implanted medical devices.

Cirtec Medical will attend the event at Galway Racecourse on 23 and 24 September 2026, where visitors to Booth L132 will be able to learn more about Stereax and its role in next-generation medical device development.

The event gives Ilika direct exposure to companies operating across the medical technology sector. Stereax is being positioned for applications where compact solid-state batteries can support active implanted devices, making MedTech Ireland a relevant setting for presenting the technology to potential customers and development partners.

Cirtec Medical works with medical device companies from initial concept through to commercialisation and scale-up. Its capabilities include rapid prototyping, complex design, product development and manufacturing.

Medical Technology Ireland Expo and Conference – 23-24 September 2026, Galway Racecourse

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Ilika advances Goliath towards commercial deployment

Ilika is advancing Goliath through testing and manufacturing scale-up while targeting shorter-cycle markets alongside longer-term electric vehicle adoption.

Ilika builds the manufacturing path for Goliath solid-state batteries

Ilika is building the manufacturing and licensing pathway needed to move its Goliath solid-state battery technology towards larger-scale commercial production.

Ilika: Stereax revenue growth and Goliath opportunities ahead

Morphose Capital Partners’ Dr Tom McColm discusses Ilika’s FY26 results, the outlook for Stereax commercial revenues, progress with Goliath and potential opportunities in automotive, defence and e-bikes.

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Search